ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,955.25
      -0.47%
      US Tech 100
      20,617.60
      -0.85%
      Dow Jones
      43,621.16
      0.37%
      Brent Oil
      72.725
      0.19%
      Bitcoin
      88,693.66
      0.07%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Channel Therapeutics Corporation (CHRO) Quote

      Channel Therapeutics Corporation

      Channel Therapeutics Corporation (CHRO)

      AMEX
      1.78
      0.03
      (1.71%)
      Closed February 25 4:00PM
      Delayed by 15 minutes
      1.90
      0.12
      (6.74%)
      After Hours: 7:45PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      1.90
      Bid
      -
      Ask
      -
      Volume
      31,951
      1.6861 Day's Range 1.96
      0.45 52 Week Range 4.74
      Market Cap
      11.453M
      Previous Close
      1.75
      Open
      1.72
      Last Trade
      1
      @
      1.9
      Last Trade Time
      Financial Volume
      $ 58,837
      VWAP
      1.8415
      Average Volume (3m)
      999,778
      Shares Outstanding
      6,028,011
      Dividend Yield
      -
      PE Ratio
      -1.58
      Earnings Per Share (EPS)
      -1.22
      Revenue
      -
      Net Profit
      -7.38M

      About Channel Therapeutics Corporation

      Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. I... Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      channeltherapeutics.com
      Headquarters
      Reno, Nevada, USA
      Founded
      -
      Channel Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker CHRO. The last closing price for Channel Therapeutics was $1.75. Over the last year, Channel Therapeutics shares have traded in a share price range of $ 0.45 to $ 4.74.

      Channel Therapeutics currently has 6,028,011 shares outstanding. The market capitalization of Channel Therapeutics is $10.55 million. Channel Therapeutics has a price to earnings ratio (PE ratio) of -1.58.

      Ask ADVFN Intelligence (AI)

      CHRO Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      June 18 2024
      CHRO (1.71%)

      Form 424B3 - Prospectus [Rule 424(b)(3)]
      Edgar (US Regulatory)
      May 15 2024
      CHRO (1.71%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 15 2024
      CHRO (1.71%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.010.5291005291011.891.971.59264601.7183849CS
      4-0.2-9.523809523812.12.681.2203883471.91388565CS
      121.2559194.9852507370.64413.80.55139997782.268323CS
      260.973104.9622437970.9273.80.455068982.07038861CS
      52-2.41-55.91647331794.314.740.452631502.05704932CS
      156-4.1-68.3333333333660.452590212.067942CS
      260-4.1-68.3333333333660.452590212.067942CS

      CHRO - Frequently Asked Questions (FAQ)

      What is the current Channel Therapeutics share price?
      The current share price of Channel Therapeutics is $ 1.90
      How many Channel Therapeutics shares are in issue?
      Channel Therapeutics has 6,028,011 shares in issue
      What is the market cap of Channel Therapeutics?
      The market capitalisation of Channel Therapeutics is USD 10.55M
      What is the 1 year trading range for Channel Therapeutics share price?
      Channel Therapeutics has traded in the range of $ 0.45 to $ 4.74 during the past year
      What is the PE ratio of Channel Therapeutics?
      The price to earnings ratio of Channel Therapeutics is -1.58
      What is the reporting currency for Channel Therapeutics?
      Channel Therapeutics reports financial results in USD
      What is the latest annual profit for Channel Therapeutics?
      The latest annual profit of Channel Therapeutics is USD -7.38M
      What is the registered address of Channel Therapeutics?
      The registered address for Channel Therapeutics is 50 WEST LIBERTY STREET, SUITE 880, RENO, NEVADA, 89501
      What is the Channel Therapeutics website address?
      The website address for Channel Therapeutics is channeltherapeutics.com
      Which industry sector does Channel Therapeutics operate in?
      Channel Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CTMCastellum Inc
      $ 0.975199
      (25.03%)
      		8.18M
      MSTZT Rex 2X Inverse MSTR Daily Target ETF
      $ 27.95
      (23.13%)
      		26.9M
      BEEPMobile Infrastructure Corporation
      $ 3.52
      (21.38%)
      		134.15k
      TSLZT Rex 2X Inverse Tesla Daily Target ETF
      $ 3.835
      (16.74%)
      		103.57M
      IBIOiBio Inc
      $ 3.9245
      (14.08%)
      		2.17M
      ATCHAtlasClear Holdings Inc
      $ 3.85
      (-30.76%)
      		2.84M
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 4.865
      (-22.78%)
      		96.93M
      FOXOFOXO Technologies Inc
      $ 0.1602
      (-19.09%)
      		6.02M
      SOARVolato Group Inc
      $ 2.11
      (-17.87%)
      		230.71k
      TSLTT Rex 2X Long Tesla Daily Target ETF
      $ 19.72
      (-16.86%)
      		8.21M
      TSLZT Rex 2X Inverse Tesla Daily Target ETF
      $ 3.835
      (16.74%)
      		103.57M
      MSTUT Rex 2X Long MSTR Daily Target ETF
      $ 4.865
      (-22.78%)
      		96.93M
      SPXSDirexion Daily S&P 500 Bear 3X Shares New
      $ 6.10
      (1.33%)
      		95.79M
      ETHU2x Ether ETF
      $ 3.715
      (-11.34%)
      		95.31M
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 25.07
      (-6.32%)
      		90.91M

      CHRO Discussion

      View Posts
      glenn1919 glenn1919 2 weeks ago
      CHRO.........................https://stockcharts.com/h-sc/ui?s=CHRO&p=W&b=5&g=0&id=p86431144783
      👍️0
      Invest-in-America Invest-in-America 1 month ago
      CHRO: Whelp, looks like we can all thank iHub's Colonel GLENN, on THAT note now, Homeboy.
      👍️0
      tw0122 tw0122 1 month ago
      $3.08 + 60% Meant to tell you a Friday when still in $1s to
      Open board but you got it done 
      👍️0
      Invest-in-America Invest-in-America 1 month ago
      CHRO: Micro-FLoat, NO-BRAINER!!
      👍️0
      Invest-in-America Invest-in-America 1 month ago
      CHRO: WOW!!
      👍️0
      glenn1919 glenn1919 1 month ago
      CHRO............................https://stockcharts.com/h-sc/ui?s=CHRO&p=W&b=5&g=0&id=p86431144783
      👍️0

      Your Recent History

      AMEX
      CHRO
      Channel Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads